Diana Serebryanik

Diana Serebryanik currently serves as the Head of US Quality Control at Galapagos, overseeing the quality control for the decentralized CAR-T manufacturing model since January 2025. Diana has prior experience as a Quality Control professional at Cellares, focusing on QC method transfer for CAR-T cell therapies in late 2024. From September 2019 to November 2023, Diana held the position of Director of Quality Control at Rocket Pharmaceuticals, emphasizing GMP standards and quality control expertise. Earlier roles include Associate Director of Quality Control at Novartis, with responsibilities in CAR-T and quality investigations, and various positions at Dendreon, culminating in the role of QC Supervisor. Diana holds a Bachelor's degree in Biochemistry from Brandeis University and has additional educational credentials from Boston University.